FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175095263> ?p ?o ?g. }

• W3175095263 endingPage "1836" @default.
• W3175095263 startingPage "1827" @default.
• W3175095263 abstract "Chemoprevention curcumin Analog-1.1 (CCA-1.1) demonstrates antineoplastic effect toward cancer cells. By using triple-negative breast cancer (TNBC), 4T1, and human epidermal growth factor receptor 2 (HER2)-enriched metastatic cells (MCF-7/HER2), we evaluate the cytotoxic and antimigration activities from CCA-1.1.The cytotoxic activities from a single treatment of CCA-1.1 and in combination with doxorubicin were determined through MTT assay. We also calculated the selectivity index and combination index of CCA-1.1 from the cytotoxic data. Migrating cells were evaluated using wound healing assay, and the MMP2 and MMP9 secretion levels were determined through gelatin zymography.As hypothesized, CCA-1.1 performed cytotoxic activity during treatment in 4T1 and MCF-7/HER2 cancer cells with good selectivity (Selectivity Index >2). In addition, CCA-1.1 demonstrated a synergistic effect in combinatorial treatment with a low dose of doxorubicin. A single treatment of CCA-1.1 repressed cell migration in 4T1 and MCF-7/HER2 cells. Under gelatin zymography, CCA-1.1 subsided the activities of MMP-9, thereby revealing the potency of CCA-1.1 as an anti-migratory agent. Moreover, MMP-9 was also eminently expressed in TNBC and HER2-enriched breast cancer cells when compared with that in other subtypes.Our preliminary study collectively reinforces the potential effect of CCA-1.1 through the inhibition of highly aggressive cell migration, particularly in breast cancer." @default.
• W3175095263 created "2021-07-05" @default.
• W3175095263 creator A5009026673 @default.
• W3175095263 creator A5013086305 @default.
• W3175095263 creator A5037955020 @default.
• W3175095263 creator A5071211913 @default.
• W3175095263 creator A5075592755 @default.
• W3175095263 date "2021-06-01" @default.
• W3175095263 modified "2023-10-17" @default.
• W3175095263 title "CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells" @default.
• W3175095263 cites W1943317391 @default.
• W3175095263 cites W1977918192 @default.
• W3175095263 cites W1980671878 @default.
• W3175095263 cites W1989789339 @default.
• W3175095263 cites W1993023973 @default.
• W3175095263 cites W2003432147 @default.
• W3175095263 cites W2003500892 @default.
• W3175095263 cites W2005334224 @default.
• W3175095263 cites W2019267973 @default.
• W3175095263 cites W2030694827 @default.
• W3175095263 cites W2030786088 @default.
• W3175095263 cites W2061601119 @default.
• W3175095263 cites W2067413770 @default.
• W3175095263 cites W2096439168 @default.
• W3175095263 cites W2108215899 @default.
• W3175095263 cites W2119104290 @default.
• W3175095263 cites W2132799659 @default.
• W3175095263 cites W2147510154 @default.
• W3175095263 cites W2153150070 @default.
• W3175095263 cites W2226783953 @default.
• W3175095263 cites W2604248127 @default.
• W3175095263 cites W2614027162 @default.
• W3175095263 cites W2754516505 @default.
• W3175095263 cites W2767624974 @default.
• W3175095263 cites W2777753697 @default.
• W3175095263 cites W2799771420 @default.
• W3175095263 cites W2893052697 @default.
• W3175095263 cites W2902357747 @default.
• W3175095263 cites W2902506814 @default.
• W3175095263 cites W2938150871 @default.
• W3175095263 cites W2941031197 @default.
• W3175095263 cites W2963875030 @default.
• W3175095263 cites W2981907495 @default.
• W3175095263 cites W2999529909 @default.
• W3175095263 cites W3036257325 @default.
• W3175095263 cites W3085957763 @default.
• W3175095263 cites W3115485046 @default.
• W3175095263 doi "https://doi.org/10.31557/apjcp.2021.22.6.1827" @default.
• W3175095263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8418863" @default.
• W3175095263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34181339" @default.
• W3175095263 hasPublicationYear "2021" @default.
• W3175095263 type Work @default.
• W3175095263 sameAs 3175095263 @default.
• W3175095263 citedByCount "7" @default.
• W3175095263 countsByYear W31750952632022 @default.
• W3175095263 countsByYear W31750952632023 @default.
• W3175095263 crossrefType "journal-article" @default.
• W3175095263 hasAuthorship W3175095263A5009026673 @default.
• W3175095263 hasAuthorship W3175095263A5013086305 @default.
• W3175095263 hasAuthorship W3175095263A5037955020 @default.
• W3175095263 hasAuthorship W3175095263A5071211913 @default.
• W3175095263 hasAuthorship W3175095263A5075592755 @default.
• W3175095263 hasBestOaLocation W31750952631 @default.
• W3175095263 hasConcept C121608353 @default.
• W3175095263 hasConcept C126322002 @default.
• W3175095263 hasConcept C154317977 @default.
• W3175095263 hasConcept C185592680 @default.
• W3175095263 hasConcept C202751555 @default.
• W3175095263 hasConcept C2776694085 @default.
• W3175095263 hasConcept C2778250585 @default.
• W3175095263 hasConcept C2780110267 @default.
• W3175095263 hasConcept C2781303535 @default.
• W3175095263 hasConcept C502942594 @default.
• W3175095263 hasConcept C530470458 @default.
• W3175095263 hasConcept C55493867 @default.
• W3175095263 hasConcept C71924100 @default.
• W3175095263 hasConcept C86803240 @default.
• W3175095263 hasConcept C96232424 @default.
• W3175095263 hasConcept C98274493 @default.
• W3175095263 hasConceptScore W3175095263C121608353 @default.
• W3175095263 hasConceptScore W3175095263C126322002 @default.
• W3175095263 hasConceptScore W3175095263C154317977 @default.
• W3175095263 hasConceptScore W3175095263C185592680 @default.
• W3175095263 hasConceptScore W3175095263C202751555 @default.
• W3175095263 hasConceptScore W3175095263C2776694085 @default.
• W3175095263 hasConceptScore W3175095263C2778250585 @default.
• W3175095263 hasConceptScore W3175095263C2780110267 @default.
• W3175095263 hasConceptScore W3175095263C2781303535 @default.
• W3175095263 hasConceptScore W3175095263C502942594 @default.
• W3175095263 hasConceptScore W3175095263C530470458 @default.
• W3175095263 hasConceptScore W3175095263C55493867 @default.
• W3175095263 hasConceptScore W3175095263C71924100 @default.
• W3175095263 hasConceptScore W3175095263C86803240 @default.
• W3175095263 hasConceptScore W3175095263C96232424 @default.
• W3175095263 hasConceptScore W3175095263C98274493 @default.
• W3175095263 hasIssue "6" @default.
• W3175095263 hasLocation W31750952631 @default.
• W3175095263 hasLocation W31750952632 @default.

• next